167 related articles for article (PubMed ID: 22278362)
21. Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin.
Peterson EA; Kalikin LM; Steels JD; Estey MP; Trimble WS; Petty EM
Mamm Genome; 2007 Nov; 18(11):796-807. PubMed ID: 17922164
[TBL] [Abstract][Full Text] [Related]
22. High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes.
Gonzalez ME; Peterson EA; Privette LM; Loffreda-Wren JL; Kalikin LM; Petty EM
Cancer Res; 2007 Sep; 67(18):8554-64. PubMed ID: 17875694
[TBL] [Abstract][Full Text] [Related]
23. Altered patterns of transcription of the septin gene, SEPT9, in ovarian tumorigenesis.
Scott M; McCluggage WG; Hillan KJ; Hall PA; Russell SE
Int J Cancer; 2006 Mar; 118(5):1325-9. PubMed ID: 16161048
[TBL] [Abstract][Full Text] [Related]
24. Paclitaxel and vinorelbine cause synergistic increases in apoptosis but not in microtubular disruption in human lung adenocarcinoma cells (A-549).
Jung M; Grunberg S; Timblin C; Buder-Hoffman S; Vacek P; Taatjes DJ; Mossman BT
Histochem Cell Biol; 2004 Feb; 121(2):115-21. PubMed ID: 14745558
[TBL] [Abstract][Full Text] [Related]
25. Bcl-xL is phosphorylated in malignant cells following microtubule disruption.
Poruchynsky MS; Wang EE; Rudin CM; Blagosklonny MV; Fojo T
Cancer Res; 1998 Aug; 58(15):3331-8. PubMed ID: 9699663
[TBL] [Abstract][Full Text] [Related]
26. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
Ling YH; Jiang JD; Holland JF; Perez-Soler R
Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
[TBL] [Abstract][Full Text] [Related]
27. Synergistic antitumor effects of novel HDAC inhibitors and paclitaxel in vitro and in vivo.
Zuco V; De Cesare M; Cincinelli R; Nannei R; Pisano C; Zaffaroni N; Zunino F
PLoS One; 2011; 6(12):e29085. PubMed ID: 22194993
[TBL] [Abstract][Full Text] [Related]
28. Kinetic analysis of tubulin exchange at microtubule ends at low vinblastine concentrations.
Jordan MA; Wilson L
Biochemistry; 1990 Mar; 29(11):2730-9. PubMed ID: 2346745
[TBL] [Abstract][Full Text] [Related]
29. Characterization of human septin interactions.
Sandrock K; Bartsch I; Bläser S; Busse A; Busse E; Zieger B
Biol Chem; 2011 Aug; 392(8-9):751-61. PubMed ID: 21767235
[TBL] [Abstract][Full Text] [Related]
30. βII-tubulin and βIII-tubulin mediate sensitivity to peloruside A and laulimalide, but not paclitaxel or vinblastine, in human ovarian carcinoma cells.
Kanakkanthara A; Northcote PT; Miller JH
Mol Cancer Ther; 2012 Feb; 11(2):393-404. PubMed ID: 22180309
[TBL] [Abstract][Full Text] [Related]
31. Modulation of septin and molecular motor recruitment in the microtubule environment of the Taxol-resistant human breast cancer cell line MDA-MB-231.
Froidevaux-Klipfel L; Poirier F; Boursier C; Crépin R; Poüs C; Baudin B; Baillet A
Proteomics; 2011 Oct; 11(19):3877-86. PubMed ID: 21761557
[TBL] [Abstract][Full Text] [Related]
32. Septin 9 interacts with kinesin KIF17 and interferes with the mechanism of NMDA receptor cargo binding and transport.
Bai X; Karasmanis EP; Spiliotis ET
Mol Biol Cell; 2016 Mar; 27(6):897-906. PubMed ID: 26823018
[TBL] [Abstract][Full Text] [Related]
33. Resistance to microtubule-targeted cytotoxins in a K562 leukemia cell variant associated with altered tubulin expression and polymerization.
Dumontet C; Jaffrezou JP; Tsuchiya E; Duran GE; Chen KG; Derry WB; Wilson L; Jordan MA; Sikic BI
Bull Cancer; 2004 May; 91(5):E81-112. PubMed ID: 15568225
[TBL] [Abstract][Full Text] [Related]
34. Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules.
Ngan VK; Bellman K; Panda D; Hill BT; Jordan MA; Wilson L
Cancer Res; 2000 Sep; 60(18):5045-51. PubMed ID: 11016627
[TBL] [Abstract][Full Text] [Related]
35. Septin 9 isoforms promote tumorigenesis in mammary epithelial cells by increasing migration and ECM degradation through metalloproteinase secretion at focal adhesions.
Marcus J; Bejerano-Sagie M; Patterson N; Bagchi S; Verkhusha VV; Connolly D; Goldberg GL; Golden A; Sharma VP; Condeelis J; Montagna C
Oncogene; 2019 Jul; 38(30):5839-5859. PubMed ID: 31285548
[TBL] [Abstract][Full Text] [Related]
36. Imaging of hypoxia-inducible factor 1α and septin 9 interaction by bimolecular fluorescence complementation in live cancer cells.
Golan M; Mabjeesh NJ
Oncotarget; 2017 May; 8(19):31830-31841. PubMed ID: 28380438
[TBL] [Abstract][Full Text] [Related]
37. Septin 9 Exhibits Polymorphic Binding to F-Actin and Inhibits Myosin and Cofilin Activity.
Smith C; Dolat L; Angelis D; Forgacs E; Spiliotis ET; Galkin VE
J Mol Biol; 2015 Oct; 427(20):3273-3284. PubMed ID: 26297986
[TBL] [Abstract][Full Text] [Related]
38. Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents.
Wang RC; Chen X; Parissenti AM; Joy AA; Tuszynski J; Brindley DN; Wang Z
PLoS One; 2017; 12(8):e0182400. PubMed ID: 28787019
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of SEPT9_v1 stabilizes c-Jun-N-terminal kinase and contributes to its pro-proliferative activity in mammary epithelial cells.
Gonzalez ME; Makarova O; Peterson EA; Privette LM; Petty EM
Cell Signal; 2009 Apr; 21(4):477-87. PubMed ID: 19071215
[TBL] [Abstract][Full Text] [Related]
40. Nordihydroguaiaretic acid, of a new family of microtubule-stabilizing agents, shows effects differentiated from paclitaxel.
Nakamura M; Nakazawa J; Usui T; Osada H; Kono Y; Takatsuki A
Biosci Biotechnol Biochem; 2003 Jan; 67(1):151-7. PubMed ID: 12619686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
